RICOVR Healthcare

About:

RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.

Website: https://www.ricovr.com/

Twitter/X: ricovr_health

Top Investors: National Institute on Drug Abuse (NIDA), National Heart, Lung and Blood Institute, HALLEY Venture Partners

Description:

RICOVR Healthcare is a medical device company that has developed biosensor technology for rapid point-of-care testing. The company’s non-invasive portable testing devices will benefit not only employers and law enforcement but also the medical community and individuals. The novel patented technology is extremely sensitive and can quantitatively detect disease biomarkers even present in low quantity. They are currently developing testing devices for THC (the psychoactive component of Cannabis) and COVID-19. In addition, the platform has the potential to add accurate and quantitative testing for alcohol, other drugs of abuse, and infectious diseases.

Total Funding Amount:

$5.93M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2018-01-01

Contact Email:

piyush.sadana(AT)ricovr.com

Founders:

Himanshu Bhatia, Piyush Sadana

Number of Employees:

1-10

Last Funding Date:

2024-10-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai